Kalp Cancer Foundation Profile
Key Indicators
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth -70.73%
- Profit Growth -14.88%
- Ebitda 34.44%
- Net Worth 10.92%
- Total Assets 9.77%
About Kalp Cancer Foundation
Kalp Cancer Foundation (KCF) is a Private Not For Profit Company incorporated in India on 04 December 2012 and has a history of 12 years and two months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Education & Learing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.00 and a paid-up capital of Rs 0.00, as per Ministry of Corporate Affairs (MCA) records.
Mandakulvtur Subramanya, Geeta Narayanan, Aruna Eswarprasad, and Two other members serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85100KA2012NPL066993
-
Company No.
066993
-
Company Classification
Private Not For Profit Company
-
Incorporation Date
04 Dec 2012
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Kalp Cancer Foundation?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mandakulvtur Subramanya
|
Director | 04-Dec-2012 | Current |
|
Geeta Narayanan
|
Director | 04-Dec-2012 | Current |
|
Aruna Eswarprasad
|
Director | 04-Dec-2012 | Current |
|
Hema Ramamurthy
|
Additional Director | 18-May-2019 | Current |
|
Viswanathan Bhaskar
|
Additional Director | 18-May-2019 | Current |
Financial Performance of Kalp Cancer Foundation.
Kalp Cancer Foundation, for the financial year ended 2017, experienced significant reduction in revenue, with a 70.73% decrease. The company also saw a substantial fall in profitability, with a 14.88% decrease in profit. The company's net worth Soared by an impressive increase of 10.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kalp Cancer Foundation?
Unlock access to Kalp Cancer Foundation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kalp Cancer Foundation?
Unlock and access historical data on people associated with Kalp Cancer Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kalp Cancer Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kalp Cancer Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
